He said multiple global firms, including Sanofi, Opella, Vaxxinova Animal Health, Tredence and Rx Propellant, expressed interest in investing in Telangana during the summit. He added that BioAsia 2026 was the largest edition so far, drawing 4,394 registrations and facilitating more than 4,000 B2B meetings focused on partnerships, investments and market access across biopharma, medtech and digital health.The event featured over 120 startups, with over 40 exhibiting solutions in medical devices, biomarkers, nutraceuticals, AI/ML, and cell and gene therapy. The research and innovation circle of Hyderabad also launched the Telangana Hospital–Industry–Innovation Bridge to strengthen healthcare innovation, translational research and medtech manufacturing.
